MBX Biosciences, Inc. Common Stock (MBX) delivered a return of 338.01% over the past year. Since MBX does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in MBX Biosciences, Inc. Common Stock one year ago would be worth $43,801 today, representing a gain of $33,801.

MBX Biosciences, Inc. Common Stock (MBX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For MBX, the total return equals the price-only return.

Yes, MBX Biosciences, Inc. Common Stock (MBX) outperformed the S&P 500 by 317.17 percentage points over the past year. MBX delivered a total return of 338.01%, compared to the S&P 500's 20.84%. This 317.17pp alpha means investors in MBX earned more than a passive S&P 500 index fund.

MBX Biosciences, Inc. Common Stock (MBX) experienced a maximum drawdown of -37.60% over the past year, declining from its peak on 2026-01-20 to its trough on 2026-03-30. The stock recovered to its prior peak by 2026-06-22. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are MBX Biosciences, Inc. Common Stock (MBX)'s long-term returns with dividends reinvested. Over 10 years, the total return is 104.7% (7.4% CAGR) — $10,000 would have grown to $20,465. Over 20 years: 104.7% total return (3.6% CAGR) — $10,000 → $20,465. Over 30 years: 104.6% total return (2.4% CAGR) — $10,000 → $20,465. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

MBX Biosciences, Inc. Common Stock's best calendar year was 2025 with a total return of 72.8%. Its worst year was 2024 with a total return of -22.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 94.9 percentage points.